LabCorp to Acquire Sequenom for $371 million

LabCorp, a healthcare diagnostics company, has acquired Sequenom for $371 million.  Sequenom’s market-leading NIPT Testing will help advance LabCorps strategy to deliver premier diagnostics solutions.  LabCorps CEO, David King, recently stated, “This is exactly the kind of strategic acquisition that LabCorp seeks: Sequenom was the first laboratory to offer a clinically validated NIPT test and has performed more than 500,000 tests to date.”

LabCorp is the leading health diagnostics company and Sequenom is a pioneer in NIPT testing for reproductive health, so this merger is in the best interests of both companies.

Read More